The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Inhibition of LRRK2 Roc-COR GTPase
Study Rationale:
The LRRK2 protein is overactive in people with Parkinson’s and a mutation in the LRRK2 gene. Recent research shows LRRK2 may be overactive in a sporadic (cause unknown) Parkinson’s... -
Therapeutic Pipeline Program, 2019Managing Levodopa-induced Dyskinesias by Targeting Dopamine D1 Receptor Signaling
Study Rationale:
Parkinson’s is a complex brain disease caused by the gradual loss of brain cells producing the neurotransmitter dopamine, which controls movement, emotion and affect. However... -
Research Grant, 2019Tool to Identify Parkinson’s Disease Using Digital Facial Expression Biomarkers
Study Rationale:
Traditional Parkinson’s disease (PD) detection and monitoring systems lack objective biomarkers and are often reliant on late-stage symptoms. By contrast, a masked face is often seen... -
Epidemiological Parkinson's Risk Modifiers, 2019Study in Finnish Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease
Study Rationale:
Effective treatments for slowing the progression of Parkinson’s disease are urgently needed. Searching for possible treatments among drugs already used for other indications is a... -
Epidemiological Parkinson's Risk Modifiers, 2019Study in Norwegian Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease
Study Rationale:
There are not yet medicines that can prevent or slow Parkinson’s disease. Developing a new therapeutic can cost up to 2.6 billion dollars and takes many years of screening, chemistry... -
Therapeutic Pipeline Program, 2019Biomaterial-enhanced Cellular Brain Repair for Parkinson's Disease
Study Rationale:
One promising approach for the treatment of Parkinson’s is to replace the cells that have died in the disease through transplantation of healthy cells into the brain. However, this...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.